REGULUS THERAPEUTICS INC's ticker is RGLSXXXX and the CUSIP is 75915K101. A total of 53 filers reported holding REGULUS THERAPEUTICS INC in Q2 2014. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2015 | $140,000 | -27.5% | 12,783 | +5.9% | 0.13% | -31.7% |
Q4 2014 | $193,000 | -4.5% | 12,076 | -59.2% | 0.19% | -18.1% |
Q3 2014 | $202,000 | -21.7% | 29,602 | -7.9% | 0.23% | -19.2% |
Q2 2014 | $258,000 | +5.7% | 32,150 | +13.2% | 0.28% | +12.4% |
Q1 2014 | $244,000 | +68.3% | 28,410 | +44.8% | 0.25% | +58.2% |
Q4 2013 | $145,000 | – | 19,626 | – | 0.16% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 4,039,823 | $26,420,000 | 3.79% |
Foresite Capital Management II, LLC | 1,750,269 | $11,447,000 | 3.48% |
ARGONAUT CAPITAL MANAGEMENT CORP | 75,000 | $491,000 | 1.65% |
Abingworth LLP | 327,350 | $2,138,000 | 1.25% |
Trellus Management Company, LLC | 100,000 | $654,000 | 0.96% |
Cormorant Asset Management, LP | 896,522 | $5,863,000 | 0.94% |
DAFNA Capital Management LLC | 90,000 | $589,000 | 0.58% |
ORACLE INVESTMENT MANAGEMENT INC | 749,064 | $4,898,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |
Foresite Capital Management II, LLC | 250,000 | $1,635,000 | 0.50% |